Delisting riskPopularity #3,730
VolitionRx (VNRX)
Builds blood-based diagnostics from nucleosome measurement and chromatin enrichment.
$0.2456
vs last close−0.02 (−6.69%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.38
Revenue estimate
$706.4K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.20−$1.20−$1.20−$1.00−$1.05−$0.97−$0.85Pending
Estimate−$1.10−$0.86−$1.00−$0.80−$0.80−$0.70−$0.57−$0.38
Surprise−9.1%−38.9%−20.0%−25.0%−31.3%−38.6%−49.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$190.5K$250.0K$400.0K$627.3K$420.0K$985.1K$398.7KPending
Estimate$659.0K$917.1K$417.2K$1.7M$753.6K$1.5M$415.3K$706.4K
Surprise−71.1%−72.7%−4.1%−62.7%−44.3%−35.2%−4.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $11.23 | — | — |
| Sep 2028 | $10.55 | — | — |
| Jun 2028 | $10.36 | — | — |
| Mar 2028 | $10.41 | — | — |
| Dec 2027 | −$0.16 | — | — |
| Sep 2027 | −$0.15 | — | — |
| Jun 2027 | −$0.18 | — | — |
| Mar 2027 | −$0.47 | — | — |
| Dec 2026 | −$0.25 | — | — |
| Nov 2026 | −$0.38 | — | — |
| Aug 2026 | −$0.57 | −$0.85 | −49.8% |
| May 2026 | −$0.70 | −$0.97 | −38.6% |
| Mar 2026 | −$0.80 | −$1.05 | −31.3% |
| Nov 2025 | −$0.80 | −$1.00 | −25.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $11.23 | — | — | $54.9M | — | — | — |
| Sep 2028 | $10.55 | — | — | $51.2M | — | — | — |
| Jun 2028 | $10.36 | — | — | $49.6M | — | — | — |
| Mar 2028 | $10.41 | — | — | $49.2M | — | — | — |
| Dec 2027 | −$0.16 | — | — | $3.1M | — | — | — |
| Sep 2027 | −$0.15 | — | — | $995.0K | — | — | — |
| Jun 2027 | −$0.18 | — | — | $935.3K | — | — | — |
| Mar 2027 | −$0.47 | — | — | $2.0M | — | — | — |
| Dec 2026 | −$0.25 | — | — | $682.4K | — | — | — |
| Nov 12, 2026 | −$0.38 | — | — | $706.4K | — | — | — |
| Aug 13, 2026 | −$0.57 | −$0.85 | −49.8% | $415.3K | $398.7K | −4.0% | −7.0% |
| May 14, 2026 | −$0.70 | −$0.97 | −38.6% | $1.5M | $985.1K | −35.2% | −9.1% |
| Mar 31, 2026 | −$0.80 | −$1.05 | −31.3% | $753.6K | $420.0K | −44.3% | −1.0% |
| Nov 13, 2025 | −$0.80 | −$1.00 | −25.0% | $1.7M | $627.3K | −62.7% | −6.6% |
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 26, 2024 | |||||||
| Nov 15, 2023 | |||||||
| Aug 15, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 22, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 20, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 12, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 13, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 13, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 11, 2017 | |||||||
| Mar 10, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 13, 2016 | |||||||
| Mar 11, 2016 | |||||||
| Nov 4, 2015 | |||||||
| Aug 11, 2015 |